LNTH

LNTH

USD

Lantheus Holdings Inc. Common Stock

$101.770-1.990 (-1.918%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$103.760

Kõrge

$103.810

Madal

$99.747

Maht

0.13M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

7.1B

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

0.90M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $65.76Praegune $101.770Kõrge $126.89

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 26. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

LNTH (Lantheus Holdings Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: LNTH Generate Date: 2025-04-26 15:10:16

Alright, let's break down what's been happening with Lantheus stock and what the data we have might suggest. Think of this as looking under the hood to see what makes it tick right now.

Recent News Buzz: What's the Vibe?

The main piece of news we've got is pretty straightforward: Lantheus is holding its first-quarter earnings call on May 7th. This isn't news that tells us if they did well or poorly yet; it's just the announcement of when they'll tell us. It's a heads-up for investors to tune in.

Now, while this specific announcement is neutral, the recommendation data provided mentions that recent news sentiment overall has been "highly positive." This suggests that other news or general market chatter around Lantheus lately has been good, creating some positive energy around the stock leading up to this earnings report.

Price Check: What's the Stock Been Doing?

Looking back over the last few months, this stock has seen some action. It started the year around the high $90s, took a dip down into the low $80s in February, but then staged a pretty strong comeback, climbing back up and even hitting over $110 in March.

More recently, in April, the price has settled down a bit from that peak. It's been trading roughly between $95 and $104. The current price is sitting right around the $101-$103 mark. So, after that big run-up and slight pullback, it seems to be consolidating or maybe starting to edge up again.

The AI prediction for the very near term (today and the next two days) suggests a positive move, forecasting a small gain today (0.00%, essentially flat) followed by increases of around 2.8% and 3.7% over the next couple of days. This aligns with the idea that the stock might be looking to climb a bit from its current level.

Putting It Together: Outlook & Ideas

Based on the combination of factors – the upcoming, potentially market-moving earnings call, the indication of positive sentiment from other recent news, the stock's recent price recovery and current stability, and the AI's short-term positive forecast – the situation seems to lean slightly positive for the near term.

Here's the thing: The earnings call on May 7th is a big wildcard. Good results could send the stock higher, while disappointing ones could cause a drop. But leading up to it, the data suggests some positive momentum might be building.

  • Potential Entry Consideration: If you were considering getting in, the recommendation data points to potential entry areas around $103.09 and $103.71. The current price is right in this neighborhood. This area could be one to watch if you think the positive sentiment and AI prediction have legs before the earnings report.
  • Potential Exit/Stop-Loss Consideration: To manage risk, the recommendation data suggests a stop-loss level around $93.27. This is below the recent trading range and could be a point to consider exiting if the stock turns south unexpectedly. For potential gains, the recommendation data suggests a take-profit level around $110.58. This is close to the recent March peak and could be a target if the stock rallies.

Remember, these are just potential levels based on the provided data and analysis, not guarantees.

Company Context

Just a quick note on what Lantheus actually does: They're in the healthcare sector, specifically making diagnostic and therapeutic products. Think things that help doctors see what's going on inside the body (like imaging agents for cancer or heart issues) and some treatments too. They're also dabbling in AI tools for analyzing medical images. This means news about their specific products, clinical trials, or sales figures (which we'll hear about in the earnings call) are really important drivers for the stock price.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Seotud uudised

GlobeNewswire

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 7, 2025, to

Vaata rohkem
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 11:04

LangevNeutraalneTõusev

73.3% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$101.33

Võta kasum

$108.49

Peata kahjum

$91.59

Põhitegurid

PDI 10.5 on MDI 5.5 kohal ADX-iga 12.4, mis viitab tõusutrendile
Praegune hind on tugitasemele ($101.22) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 10.2x keskmisest (8,795), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0806 on signaalijoone 0.0440 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.